VSV-GP128
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VSV-GP128, covering 2025-01-29 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer [Phase 1]